Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
Qingyun Zhu, Qiuzi Dai, Lei Zhao, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

The balance of STING signaling orchestrates immunity in cancer
Klara Rasmussen Bollerup Lanng, Emil Leth Lauridsen, Martin R. Jakobsen
Nature Immunology (2024) Vol. 25, Iss. 7, pp. 1144-1157
Closed Access | Times Cited: 37
NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis
Zimu Wang, Jing Luo, Hairong Huang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Anticancer properties of histone deacetylase inhibitors – what is their potential?
Kajetan Kiełbowski, Agata Szwedkowicz, Paulina Plewa, et al.
Expert Review of Anticancer Therapy (2025), pp. 1-16
Closed Access | Times Cited: 1
STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems
Hitesh Vasiyani, Bhumika Wadhwa
Cellular Signalling (2025), pp. 111647-111647
Closed Access | Times Cited: 1
The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 5
Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy
Weiyue Zhang, Xin Huang
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Recent Progress in Poly(ADP–Ribose) Polymerase‐1 Inhibitors for Application in Cancer
Anuradha Mehra, Sayemul Islam, Rekha Sangwan
ChemistrySelect (2025) Vol. 10, Iss. 1
Closed Access
A Molecular‐Targeting Photosensitizer to Inhibit DNA Damage Repair System and Induce cGAS‐STING Pathway Activation for Photo‐Immunotherapy of Ovarian Cancer
Lianfeng Fan, Peng Zhang, Youyu Gan, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 1
Synergistic Cytotoxicity of Histone Deacetylase and Poly-ADP Ribose Polymerase Inhibitors and Decitabine in Breast and Ovarian Cancer Cells: Implications for Novel Therapeutic Combinations
Benigno C. Valdez, Apostolia M. Tsimberidou, Bin Yuan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9241-9241
Open Access
Advances in Epigenetic Therapeutics for Breast Cancer
Michel-Gael F. Guefack, Sanchita Bhatnagar
Advances in experimental medicine and biology (2024), pp. 89-97
Closed Access
Antimitotic chemotherapy promotes tumor NF-kB secretory phenotype and immunosuppressive CXCR2+ neutrophils chemotaxis in triple-negative breast cancers
Florian Chocteau, Fabien Gautier, Vanessa Josso, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Page 1

Scroll to top